To keep up-to-date on our progress, sign up for the BMC CAR T information series, including articles, webinars, and more.

Developing a program to overcome barriers to cancer care

Fabio Petrocca, MD, a hematologist and oncologist with more than 15 years of experience in the field, has witnessed the journeys of hundreds of patients treated with CAR T-cell therapies.

Petrocca joined BMC with the aim of helping BMC build the hospital's first CAR T-cell treatment option under the cellular therapy program.

Fabio Petrocca, MD

Why CAR T-cell Therapy?

CAR T-cell therapy uses genetically engineered versions of a patient's own immune cells to seek and destroy tumor cells. It is a one-time treatment that takes 2 to 3 months, with most of the time in the cell production and post-treatment monitoring phases. "As one-time treatments, cell therapies can be especially beneficial for patients who experience inconsistent access to healthcare services," says Petrocca.

Among patients with myeloma, all of whom received CAR T-cell therapy on a clinical trial, only 1% were African American, and 5.4% were Hispanic.

7.3% of all patients infographic
2X the risk infographic
50% less likely infographic
20% of all cases infographic
CAR T infographics

Dr. Matthew Kulke, BMC's chief of hematology/oncology and co-director of the Cancer Center, acknowledges there are already phenomenal CAR T treatment programs around the world — "but what sets BMC apart is the patients we serve."

Meet the CAR T-cell Team

After more than a year of planning and development across many teams, clinicians, and hospital administrators, Dr. Petrocca and his collaborators plan to begin administering CAR T-cell therapy to the first patient later this year.


When Will CAR T-cell Therapy be Available at BMC?

Boston Medical Center (BMC) is eager to share that it is now offering personalized CAR T-cell therapies to patients with tough-to-treat blood cancers, including lymphomas, some leukemias, and multiple myeloma.

Learn more about BMC's CAR T-cell Therapy Program. To refer a patient, please contact car-t@bmc.org.

To keep up-to-date on our progress, sign up for the BMC CAR T information series, including articles, webinars, and more.

Read the Full Article on HealthCity

HealthCity is Boston Medical Center's online publication that explores the most pressing issues in healthcare. At HealthCity, we believe that healthcare must transform itself to become more equitable, sustainable, and open source.